5 stocks to buy with £20k in a Stocks and Shares ISA

Rupert Hargreaves looks at five stocks he’d buy today for his Stocks and Shares ISA with £20,000 and a long-term outlook.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Using a Stocks and Shares ISA is one of the best ways to invest in the market. Any income or capital gains earned on assets held within one of these wrappers doesn’t attract any further tax. Investors don’t even need to declare the income on their tax returns.

I try to make the most of my £20k ISA allowance every year as soon as possible. Here are five stocks I’d buy with my latest allowance today.

Stocks and Shares ISA

Thanks to the tax benefits of an ISA, I think they’re the perfect wrappers in which to own income investments.

I’d buy FTSE 100 healthcare stocks Hikma and GlaxoSmithKline with a portion of my £20,000 investment on this theme. 

Hikma manufactures a range of generic, low-cost medications. Meanwhile, Glaxo is more of a healthcare conglomerate, with treatments spanning from vaccines to oncology and an extensive consumer healthcare portfolio. This mixture provides healthy cash flows to support the firm’s large dividend yield of 5.6%. 

Hikma is more of a dividend growth investment. The stock offers a dividend yield of 1.5%, at the time of writing. Over the past five years, as the company’s earnings have expanded, its per-share dividend has grown at a compound annual rate of nearly 10%. As such, over the long term, I think this could be a fantastic income investment. 

Of course, these assets aren’t risk-free. Dividends are paid out of profits, and if the income at Glaxo or Hikma falls, the payouts could be slashed. Any number of factors could lead to this outcome. A sudden unforeseen economic downturn, legal battle, or higher than expected costs could significantly reduce earnings power. 

Despite these risks, I’d buy Glaxo and Hikma for my Stocks and Shares ISA portfolio today. 

Steady income 

Two other income plays I’d buy are Assura and Airtel Africa. Assura owns medical facilities in the UK, which it leases to healthcare providers. Airtel owns mobile phone towers across Africa.

The stocks offer dividend yields of 3.7% and 4.9% respectively. These payouts aren’t guaranteed. Both companies also use a lot of debt to fund their operations, which could limit their ability to grow the distributions in the long run. 

Still, I’d buy the equities for my Stocks and Shares ISA due to their cash flows from stable infrastructure assets. 

Growth investment 

The final company I’d buy for my £20,000 portfolio is a growth investment. Spirent Communications develops technology for the communications industry, in particular equipment used in 5G networks.

The 5G global services market is expected to grow at a compound annual growth rate of 46.2% from 2021 to 2028. I think if Spirent can grab just a tiny share of this market, it could be an excellent growth investment. 

The main challenge the business faces is standing out in such a competitive market. The market may also not live up to growth expectations. This could mean Spirent’s long-term growth is lower than expected. 

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has recommended GlaxoSmithKline and Hikma Pharmaceuticals. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Black woman using loudspeaker to be heard
Investing Articles

A SIPP opened at birth could be worth £10m in 55 years

The SIPP is an incredible vehicle for building wealth and saving for retirement. Many Britons just don't realise how early…

Read more »

Young Caucasian woman at the street withdrawing money at the ATM
Investing Articles

2 passive income ideas for a Stocks and Shares ISA

Looking for passive income stocks in April? Here are two high-quality FTSE 250 dividend shares to consider buying for an…

Read more »

Front view of aircraft in flight.
Investing Articles

£5,000 invested in Wizz Air shares 2 days ago is now worth…

This week has been a rather good one for beaten-down Wizz Air shares. What would have happened to a £5,000…

Read more »

Road trip. Father and son travelling together by car
Investing Articles

How much do you need in an ISA for £1,000 a week in passive income?

Ben McPoland highlights a FTSE 250 stock down by more than 25% that offers good value and an attractive 5.5%…

Read more »

A row of satellite radars at night
Investing Articles

Is Elon Musk about to send this FTSE 100 stock into orbit?

This year is shaping up to be a big one for this FTSE 100 stock and part of the reason…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Up 50% in a month! Meet Quadrise, the soaring UK penny stock that offers an alternative to oil

Mark Hartley takes a closer look at a British penny stock that envisions a future less dependent on crude oil.…

Read more »

Senior couple crossing the road on a city street. They are walking with shopping bags while Christmas shopping.
Investing Articles

How much do I need in a SIPP for a £500 monthly passive income?

Looking to earn a reliable passive income from your SIPP? Royston Wild explains how this could be possible with some…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

A P/E ratio of less than 7. Is this a red-hot value share to consider now?

James Beard uses a popular tool to identify a UK share that’s potentially undervalued. But he reckons judgement is also…

Read more »